On Air Now

Listen

Listen Live Now » 101.9 FM Central Wisconsin

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
63° Feels Like: 63°
Wind: NE 3 mph Past 24 hrs - Precip: 0.02”
Current Radar for Zip

Today

Partly Cloudy 74°

Tonight

Partly Cloudy 54°

Tomorrow

PM Showers 71°

Alerts

Acorda's multiple sclerosis drug faces generic threat

(Reuters) - Acorda Therapeutics Inc said Actavis Plc plans to market a generic version of Acorda's multiple sclerosis treatment, Ampyra.

Ampyra, which was approved in January 2010, had net sales of $72.5 million in the first quarter ended March 31.

Acorda said Actavis has submitted a marketing approval application with the U.S. Food and Drug Administration for a generic version of the drug.

Acorda said it intends to vigorously defend its intellectual property rights.

(Reporting By Penumudi Amrutha; Editing by Sriraj Kalluvila)

Comments